Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Speaker 1 (00:02):
And over one hundred and seventy five country. Is it
all the ships to see as always? You say, maiki
to the raven and women of our United Armed Forces.
Speaker 2 (00:13):
That is the day traded trio. Are you kind of talented?
What that thing? Sirt?
Speaker 3 (00:17):
Back?
Speaker 2 (00:18):
You're at the bars consta. It's very Godwin and Sully
as the big big show rolls on.
Speaker 4 (00:21):
Hey, nice to see you again with where we will
you tell the audience where you guys were?
Speaker 2 (00:25):
Is that okay? Or is that the personal lily? I
can tell you well because about your kids and stuff.
Speaker 5 (00:28):
I never We were in New York City and the
choreographer create.
Speaker 2 (00:32):
Wait wait, wait, wait do we what in New York?
Speaker 6 (00:35):
We were dancing? I wasn't.
Speaker 2 (00:36):
Your daughter was dancing.
Speaker 5 (00:37):
My two daughters were in a piece that was up
for best choreography.
Speaker 2 (00:42):
And what was this for?
Speaker 5 (00:43):
What was it called the ACE Awards? It started the
dance teachers. It's at in New York every year. Actually
this was the first year back since coach.
Speaker 4 (00:51):
So your kids who are ones went in college, one's
going and finishing high school year. Yeah, and dancings as
long as I've known you, yes, are now making the
big time.
Speaker 5 (00:58):
Well yes, their choreographer. Is that for best choreography? So
their choreographer was the one that received the ward officially.
Speaker 2 (01:04):
Of course he or she is not going to bring
on dancers and aren't.
Speaker 3 (01:07):
Top notes right?
Speaker 5 (01:08):
And all the other dancers there were Broadway dancers or
professional dancing.
Speaker 2 (01:12):
Your keep right up?
Speaker 6 (01:13):
Oh we won? I mean it was.
Speaker 5 (01:15):
And some people don't know who Derek Cuff is, but
you did Derek Cuff.
Speaker 2 (01:20):
From Dancing with You have no idea today, that's crap. Okay,
I have no idea.
Speaker 5 (01:25):
Who was Kenny or Taga or Misty Copelan anyone?
Speaker 7 (01:30):
Well?
Speaker 2 (01:30):
Color she what she said?
Speaker 7 (01:32):
She?
Speaker 6 (01:34):
You tag?
Speaker 5 (01:34):
He choreographedies and my Newsy the movie News, yes, okay.
Speaker 6 (01:42):
And Thanna do which I love.
Speaker 4 (01:43):
But high school musical John Roller Skates.
Speaker 2 (01:48):
We know that one.
Speaker 6 (01:49):
He's a very famous choreographer.
Speaker 2 (01:51):
He want to let him.
Speaker 6 (01:52):
Achieven ore that nice?
Speaker 5 (01:52):
So he was there watching my kids dance. They it
was they were in front of the top dancers of
the whole or was it held in New York City
at the Hilton Midtown's.
Speaker 2 (02:01):
I was just in. How the other celebrities that we
would know?
Speaker 5 (02:04):
Yeah, no, Abby Lead from Dance Moms, any.
Speaker 2 (02:07):
One Oh yeah, I love her rolls, right.
Speaker 6 (02:10):
I don't think it was probably anyone.
Speaker 2 (02:11):
Was Derek Jeter there, former captain of New York game. Yeah, well.
Speaker 4 (02:21):
Some guy that you used to play at the at
the Carlisle. You know that Bobby uh the piano player
of the Carlisle Hotel. No, I don't know what we saw.
Speaker 2 (02:28):
We saw We saw Danny Terrio.
Speaker 4 (02:32):
You know, Danny was one of the most famous dancers
ever in the history of television.
Speaker 2 (02:36):
Is that solid? Yeah?
Speaker 6 (02:38):
Yeah, I do.
Speaker 4 (02:40):
I love how we fought city here. Earlade analyst is
right there, his hood tariffs. How would you ever go
to those dancing sort of sort of.
Speaker 8 (02:51):
Do you ever got every night?
Speaker 2 (02:54):
Did we go to Wicked together? Do you go to
Wicked with me? We go to Wicked together? Were you
at that thing?
Speaker 8 (02:57):
I did?
Speaker 2 (02:58):
I did? Is that we saw New York City. It's fantastic.
Speaker 6 (03:01):
I saw the outsiders?
Speaker 2 (03:02):
Did you do you go to those things? Very often?
How we live in New York? Is that? Do you
spend your time in theater stuff? Very often? Or not
very often?
Speaker 8 (03:09):
You know, they're actually pretty good about giving the local
leader seats away if you if you sign up. So
I have a couple of friends that always so occasionally
I'll get a random Wednesday ticket to a show.
Speaker 5 (03:23):
It's cool you see the outsiders. I admit I just
saw the Outsiders when I was there.
Speaker 2 (03:27):
Written by S. Hinton. That's first book I think I ever read,
or that a Lady of the Tramp can't believe. Hey, how
we uh?
Speaker 4 (03:33):
My question is on this on the trip administration reversing
course allowing limited exports to those chips in exchange for
Nvidia and Amy agreeing to pay some fifteen percent of
their China sales to the government, which is nothing more
than a terror for attacks.
Speaker 2 (03:47):
What do the proponents say of this and what the
what are the opponents say?
Speaker 4 (03:50):
The opponents just think it's a money ground, I'm assuming,
but there's probably a bigger picture going here, don't you think.
Speaker 8 (03:55):
Yeah, the the opponents say it's you know, more than
a tax, because it's kind of like a forced bribe
for letting this happen. Usually what happens is we're more
principled about things with export controls. We say this is
a free market, except we believe this is a national
security threat. We believe that this is you know, a
(04:15):
violation of human rights. So we're not going to allow
this to be exported or this activity to happen. In
this case, we're being transactional about it and saying it's
fifteen percent. I actually am really split in that well,
and I'll tell you why.
Speaker 4 (04:32):
Wait wait wait wait wait, here's my question. Aren't you
happy that China has to have to rely on our chips? Yes,
because we're relying on our vaccines, in our in our antibiotics.
Speaker 2 (04:40):
Right.
Speaker 8 (04:41):
Yeah, No, I mean that's really compelling. I really don't
like the idea of China developing a parallel AI path
where they have the great firewall and censorship ability and
circuit breakers that they're in control of. That that doesn't
appeal to me at all. On the flip side, we've
been doing business.
Speaker 2 (04:59):
You're say that nothing is Yeah, Vidia is not going
to change the.
Speaker 8 (05:03):
World more liberal freedom McDonald's everywhere.
Speaker 4 (05:07):
No, it's true that thirty years of progress as resulted
in zero progress is what you're saying, talk about our
top heavy economy. We have a chart that you've pulled up.
Guys there if you have that back in the in
the controno christy uh viewing our directing as Jared Coleman
once again, no one knows where he is.
Speaker 2 (05:25):
I think I know.
Speaker 4 (05:27):
But talk about what we're looking here. It says net
income growth rebalanced. Actually the top ten top ten.
Speaker 2 (05:32):
What does that?
Speaker 4 (05:32):
What does all that mean to us in terms of
the S and p's biggest companies pulling away from the pack.
Does that mean that we don't need to throw a
dart at the at the Wall Street journaling more to
pick our best docs? We can just we can just
buy buy Spider in exchange traded fund that follows the
S and P.
Speaker 8 (05:46):
Yeah, so this is kind of showing that everything but
the big tech companies are kind of flat. I mean,
this does not account for inflation.
Speaker 1 (05:55):
Uh.
Speaker 8 (05:55):
You see that we have the little dip from Covid
at the beginning on the blue line, and then it
kind of stays flat. It goes up to about one
hundred and twenty percent, but there's been about twenty five
percent cumulative inflation since twenty nineteen. So you know, basically,
if you're not the top ten companies in the S
and P five hundred, you haven't really grown it at all.
(06:16):
So that's what worry.
Speaker 4 (06:18):
But think about this in terms of stock, in terms
of investing and such. If you were to buy the
QQQ that represents a NAZAK one hundred is an exchange
traded fund that is basically that's basically represents the one
hundred Nasdaq socks.
Speaker 2 (06:31):
It's like it's like a mutual fund.
Speaker 4 (06:32):
It's a basket of stocks, but it's traded like a
stock to where it's it's kind of fund manager als.
Speaker 2 (06:36):
So that's QQQ.
Speaker 4 (06:38):
Spy is called the spider. Does the same thing for
the SB five hundred? Are we thinking that S and
P five hundred? And I think it's always you know,
this has always been the benchmark. Is if you dollar
cost average and buy one hundred dollars of sm P
five hundred from the time that you're twenty one years
old till the time that you're fifty five years old,
you're probably gonna be pretty well set in terms of that. Yeah,
this is this change anything. I don't think I don't
(06:58):
think there's any different is it.
Speaker 8 (06:59):
I don't think that that assumption changes. But it does
tell you where the economy is right now. That is, basically,
if you're not one of the top ten big guys,
you're not profitable.
Speaker 2 (07:10):
You're not profitble.
Speaker 8 (07:11):
I mean, yeah, right, And how good can that be?
I could, I could pull this chart for the queues.
There's nothing wrong with the Q index. I so macro
analysis off of the S and P, which is there's.
Speaker 2 (07:24):
Well, what's here's here's what's interesting. Here's what's interesting.
Speaker 4 (07:27):
Profit margins in the seventies or ten twelve percent, that
was a decent pro there's the standard profit margins you'd expect.
Speaker 2 (07:35):
Okay, yep. Profit margins these days are.
Speaker 4 (07:38):
One two percent, mostly across the board, which is not
healthy if you talk about small business, I'm talking about.
Speaker 8 (07:45):
One of the reasons why companies are so popular.
Speaker 2 (07:47):
Yeah, well, because it's a widening gap.
Speaker 4 (07:49):
I mean, is that really what it comes down to
is there's a widening split between what S and P
is doing in the larger companies. Now, is that a
function of more efficiency or is that a function of
just being bigger because you can take it advantage of
a tax code that that we all try to take
advantage of, and and tax avoidance versus tax tax evasion.
Speaker 8 (08:06):
No, I think that's a I think that's a good
call out. The tech companies are first in line and
best able to use the gains from technology, right, so
everyone got more efficient when computers were put in, everyone
got more efficient. When the Internet happened, everyone got more efficient.
When you know Excel became uh used for bookkeeping and
for operations management. I mean, these are all flows that
(08:28):
happened to the tech industry first and then went into
the rest of the economies.
Speaker 2 (08:34):
Part of what we're seeing it it's innovation, is what
you're saying, right.
Speaker 8 (08:37):
Yeah, how companies probably have higher speed of innovation. Yeah.
Speaker 1 (08:41):
How he fund is our market analyst here on the
Big Bis show. Obvious enough looks like Ralf Maccio in
The Outsiders.
Speaker 2 (08:46):
The movie. Howe.
Speaker 1 (08:49):
If we're looking at this chart a year from now,
maybe after terrorists and stuff have taken effect, is the
blue line a little higher up, a little closer to
the purple line?
Speaker 8 (09:00):
Maybe not a year from now. If you take the
bookcase to the tariffs and you say they're going to
bring more manufacturing, more production into the United States for goods,
not necessarily services for goods, then maybe it takes five
years to start seeing an effect. But you're seeing more
produced in the United States now. As far as a growth,
which is what this curve is, you will see that
increase because you will see the production in the US increase,
(09:23):
but you wouldn't necessarily see that in profit margin, like
Selly was saying, because people went offshore because of the
profit margin. The President's just saying, listen, I know you
were making twenty percent by sending it offshore when you
were making ten percent on shore. Well, now you're all
gonna be making nine percent. So pick one. If you're
going to make nine percent, come over to the US.
Speaker 4 (09:41):
Here's my question for you before you get out of here.
Just the biggest surprise. I know the answer to this,
but talk about cumulative inflation since the year right before
COVID started, which the last time I remember was twenty nineteen.
So in the last six years, our cumultive inflation is
what percent?
Speaker 8 (09:55):
Yeah, I mean literally, you're just mathematically. The way to
think about this is you hear the inflation numbers every year,
and what is that number? What goes up? It's become
twenty five nine twenty.
Speaker 4 (10:08):
Five point seven percent inflation in the last six years. Now,
this is why you cannot keep your money. You have
to have your money at risk. You can't keep your
money in a savings account or under the mattress. You've
got to have your money at risk. It's got to
be growing for you with the ups and the downs,
because if you're not, if you don't do that, Howie,
on Monday morning or Friday morning, I want you to
(10:29):
on the air, I want you to explain to everybody
the rule of seventy twos because basically it's going to
tell you how many years, based upon inflation, your money will.
Speaker 2 (10:35):
Be worth half. Right, long story short, there he goes.
HOWI thank you bout appreciate time.
Speaker 1 (10:40):
How we fun market analysts here on the Big Biz Show.
All right, there is much more to come your way.
Please do not go anywhere or back after this big
(11:21):
this show at the beautiful day here in southern California
where are inside the lock one hundred studios. That music
you hear in the background is the world famous, incredibly
talented day Trader Trio. We are lucky enough to be
able to sit and listen to these guys every single
(11:41):
episode of The Big Biz Show. It is Mary burg Goblin.
I am costa little mini edition of None of Business.
Sully will be back in just a second. Gentlemen, thank
you as always, and Mary, we always love talking with
our next guest, John. You is the CEO Cairo's Pharma
and their ticker symbol is KAPA, and doctor U joins
(12:04):
us once again here on the Big Biz Show. Doctor
how are you sir? It is always great to have
you on the program. I hope everything's going well for
you this summer.
Speaker 8 (12:13):
I'm doing good.
Speaker 9 (12:14):
Thank you, Mike, thanks for having me again.
Speaker 2 (12:16):
The last time you were on.
Speaker 4 (12:17):
Since the last time you were on with us, we
have picked up a ton of new platforms where people
can go and view and listen to the Big Biz Show. So,
since we're kind of in that mode right now, can
you just give people quick the nickel version of what
you and Chiro's Pharma are all about and what you do.
Speaker 9 (12:36):
Yeah, sure, we're Chiros Pharma. Our KAPA on the nysc
American is a clinical stage biotech company that's focused on
reversing cancer drug resistance. So one of the biggest problems
in cancer is that the drugs are great, but after
a year or two, patients become resistant to these drugs.
(13:00):
The mechanism by which this happens through a protein called
CD one oh five, And we developed an antibody that
targets this protein and reverse is resistance. So we're in
a phase two trial and prostate cancer and a phase
one trial in lung cancer. We hope to show this
is a central mechanism of cancer drug resistance, not only
(13:21):
these cancers, but head and neck cancer, breast cancer, and
colon cancer. So what our drug does is it allows
drugs that fail to work after some time because of
resistance to start working again. So it works with these
other drugs too, to make patients live longer without the
scorch of cancer. Amazing a chronic disease and not something
(13:43):
that's going to kill patients within a year or two.
Speaker 2 (13:45):
It's amazing to think that.
Speaker 1 (13:46):
You know, if you're a patient, you're like, oh my god,
finally get this wonderful drug, and then after a year
or whatever, you're resistant to it. And even after you
become resistant to it, they can't just bombard you with
higher doses.
Speaker 2 (13:58):
Once you're resistant, that's it. The doors closed. It's not
going to work anymore.
Speaker 9 (14:01):
Yeah, that's what happens. Yeah, it works great until the
day that it doesn't, and then the cancer comes back.
Speaker 8 (14:06):
With a vengeance.
Speaker 9 (14:07):
And so what we want to do is stop that
cancer from coming back, really targeting this central mechanism of resistance.
Speaker 6 (14:15):
So doctor Good to see you again.
Speaker 5 (14:16):
By the way, do you do patients take your treatment
alongside the cancer drug from the beginning or just when
they you know, when you kind of anticipate when they
might start getting well.
Speaker 8 (14:31):
Yeah, that's a good question.
Speaker 9 (14:32):
So it does start after the patient gets resistant to
it or a lot of drugs like to Grisso for
lung cancer. Eighty percent of patients that actually are incompletely
treated with it. So we use our drug on top
of the drug to make them completely treated with with
with the to Grisso as well.
Speaker 1 (14:53):
Doctor John You is the CEO of Cairo's pharma Kai
r Osfarmer dot com. Tick A symbol is Kapa doctor.
If you can boast a little bit.
Speaker 4 (15:04):
I know it happened a while ago, but I think
it's always worth repeating about the grant from the Department
of Defense.
Speaker 8 (15:12):
Yeah.
Speaker 9 (15:12):
Sure, So you know, the Department of Defense gave us
a grant to look at biomarkers for lung cancer study.
What that is is gene tests that'll show which patients
will respond to our drug the best. And that's important
because we've already identified one in prostate cancer. And what
these biomarkers allow us to do is choose those patients
(15:34):
that are going to respond to our drug, and this
makes the likelihood of success of a phase three trial
go from fifty five percent to seventy six percent. So
it really increases the likelihood of success and decreases the
cost of the trial because you can put patients on
that will only the patients that will respond, so that
(15:54):
will make it a much smaller trial, more economic, more effective.
Speaker 6 (16:01):
I have a question.
Speaker 5 (16:02):
You just mentioned the prostate cancer drug, which I think
is the E and V one five.
Speaker 6 (16:08):
Yes, correct, So where you're in the phase two of that?
Is that correct? And tell me a little bit about that.
Speaker 8 (16:14):
Yes.
Speaker 9 (16:14):
So it's a randomized phase two trial where we're adding
our drug to appolludamide, which is the drug that's used
for metastatic castration resistant prostate cancer. So we'll know by
the end of this trial whether our drug really works
in reversing cancer drug resistance. And we're also trying to
show that in lung cancer in a phase one trial.
(16:36):
And so these are first two trials, but it's one
of many that will show which patients can be reversed
from their resistance.
Speaker 1 (16:47):
Doctor as far as prostate cancer is concerned, is it
one of those situations where you really don't know it's
happening until it's too late. Or is it one of
those things where most doctors, if you go in and
get your yearly check up per SE or the blood
tests whatever, can find it and get on top of
(17:08):
it if there is an issue.
Speaker 9 (17:10):
Yeah, so it is important to do examinations and PSA
tests while going on. But you know, by the time
we're eighty years old, about about fifty percent of men
have prostate cancer. Thankfully, generally it's a slow growing cancer.
At some point, you know, it becomes very aggressive and metastatic,
(17:33):
and that's when these drugs and our drugs come in.
Speaker 1 (17:37):
What's coming up as far as Kiro's Farmer is concerned
in the next eighteen months or so.
Speaker 2 (17:42):
Doctor John Hugh is the CEO of Kiro's Farmer, the
Chicker Sibyl Kapa.
Speaker 1 (17:46):
What are you looking at down the road the rest
of the year, maybe going into twenty twenty six.
Speaker 2 (17:51):
Yeah.
Speaker 9 (17:51):
So we reported our safety results last month in July,
and we're planning to release our efficacy results so far
on the prostate cancer trial, and this will be on
September eighteenth. This is the first time we're reporting this actually,
and it's going to be associated with a kol event
or a key opinion leader to talk about our drug
(18:13):
where it would stand in the treatment of a prostate
cancer and the importance of this kind of drug in
this particular disease.
Speaker 6 (18:26):
Hey, doctor, I may have asked you this before, but
I can't remember.
Speaker 5 (18:30):
Is it pretty much that every patient that is treated
for cancer will at some point become resistant to the drugs,
So this would be almost every cancer patient could potentially
use your treatment.
Speaker 9 (18:43):
Yeah, so that's exactly right, and so inevitably people become
resistant to their drugs is just a part of how
cancers work to overcome the therapies that we throw at it.
And that's why it's always a war between you know,
and cancer. And as cancer becomes resistance to our drugs,
(19:04):
then we have to find ways to you know, fight
that resistance, and then of course the cancer will figure
out the means of overcoming you know, the anti resistance
drug too, So we're always, you know, we're always trying
to out battle the cancer.
Speaker 2 (19:19):
Doctor.
Speaker 1 (19:20):
It sounds like it's one of those situations, unfortunately where
you got to hurry up and wait. But you're doing
God's work. I tell you there's so many people out there.
I'm sure everybody in this room knows somebody who's been
stricken or is battling the big fight. As we say,
John U Ceo, Cairo's Farmer, their ticker symbol KAPA website,
Chirosfarmer dot com.
Speaker 2 (19:41):
Doctor. Always great to visit with you.
Speaker 1 (19:43):
Always love hearing about the positive news that Kiro's Farmer
and you are jenerating out there for people who are
stricken with cancer. All right, lots more to come here
on this here Big b Show, Don't go anywhere. Big
(20:05):
Bit Show continues live from the lock Fun Hunter Studios,
Southern California. I'm glad you guys are all along for
this crazy ride that is the DTT day Trader Trio.
Invest in the business, No lessons self taught. Back here
at the bar, it is Costa, it is Mary Burt.
Speaker 2 (20:23):
Godwin, and it is silly. Great to have you a
long today.
Speaker 7 (20:26):
Have you.
Speaker 2 (20:28):
Reconciled the fact that cryptocurrency is here to stay? Absolutely?
Are you ready? Are you ready to trust it?
Speaker 3 (20:34):
No?
Speaker 2 (20:34):
You do already. How much money you have your wallet?
How long has it been there? You have the same pot?
Probably not use your in new York executivity.
Speaker 6 (20:39):
Yes.
Speaker 4 (20:40):
Alon Gorn, of course is the financial technology sector pioneer.
He I met Alon several years ago. I'm gonna say
maybe ten or fifteen years ago. I can't remember how
long it goes. But when he was doing the crowdfunding
came along. And now he is a founding partner of
a company called draper goran blockchain, and they invest in
crypto currency type deals along with early state it's blockchain
(21:01):
and and the digital currency companies.
Speaker 2 (21:03):
And here he is once again. He looks right, he's
right out of Menlo Park, there he is. He looks
just oh, you're cleaning up. I see all right, sand
Hill Road? Is it started to cause people to have
to shave?
Speaker 7 (21:15):
Now?
Speaker 2 (21:15):
I see you up there, buddy. How are you good
to see you?
Speaker 10 (21:19):
You know, actually I shaved just for you guys. The
way the markets are going, we're not going to have
to shave for a while.
Speaker 4 (21:27):
I have a question for you when you're investing in
you guys are a venture firm basically and almost turning
into a private equity firm, and some of your deals
are are maturing. When you're investing in krypto, Now, what
are you invest what? What is it just because the
novelty of crypto and blockchain is gone. Now it's what
are you going to do with it? And how are
we going to maximize it? And I sort of feel
(21:47):
like you remember when the Internet free Thomas Penfield Jackson
laying down the ni trust law or any trust lawsuit
judgment against Microsoft, When we had Netscape and we had
MySpace and Napster, there was a two point on internet,
which which launched Facebook and and and uh and and
the like. I mean, there's definitely a viprecation of dot
(22:08):
com U the dot com bubble as we talk about it,
and IPOs. So we we're still at one point oh
on the crypto and what's one what's two point o
look like? Because you're investing in two point oh already
even though it's not here, correct.
Speaker 10 (22:19):
Yeah, yeah, And and we you know, the way I
look at it is as a firm, we're not really
buying and selling cryptocurrencies, right, Like I've come on here.
We've talked about doge in the past, where the hawktua
coin or things like that. It's not what we do, right.
We invest in technology that we see being enabled and
(22:40):
transferring the industry ten years from now. And so where
we're at as an industry right, are that some of
the companies that we actually helped create in twenty eighteen
that we were coming on the show and talking about
are now finally getting into production with banks like JP
Morgan and stuff like that. So we had a big
exciting announcement on that actually this week with our company
own Era. But what I say when I look at
(23:03):
the industry is I actually have a slide in our deck.
I got to share this with you so you can
bring it on screen one of these times that says
nobody starts an Internet company anymore. And every single letter
in that, or most of the letters in that are
logos from Internet companies. And the reason I say that
is I show that on the screen and then out loud,
I say every company is an.
Speaker 2 (23:24):
Internet company, right exactly.
Speaker 10 (23:25):
So the hot dog stand that we might go to
out lunch is connected to the Internet through seven different
apps and you could order it on your phone if
you want to write there doesn't a company doesn't exist
that isn't an Internet company today. And where we're going
to be in a few years is that every company
will be a blockchain company. But we're not going to
talk about it that way. It's going to be part
of the infrastructure, it's going to be part of the technology,
(23:48):
and we're just going to be.
Speaker 8 (23:49):
Used to it.
Speaker 4 (23:50):
Hey, my question for you is AI, CHATGBT, blockchain and crypto.
You know there's going to be a confluence there that
changes everything, right, Yeah, US a global currency. Everything in
the world is pricing US dollars. I believe it'll stay
the global currency. But let's face it, we are a
fiat currency, mean that we don't have a gold standard,
nor does anybody else. But then here enters AI, and
(24:12):
here enters blockchain and crypto. That's got to change things
in the future. I'm sure we're probably ten years away
from that. But do you have anything on the horizon,
Alon that makes you think that this is going to
be a big change in everyone's life inter nationally?
Speaker 8 (24:25):
Yes?
Speaker 10 (24:26):
Absolutely. I think that user interface in general is totally
changing thanks to AI. We got used to asking Siri
to do things for us, right, like simple things like
making a phone call. But now Siri is directly connected
with chat, GPT, or you can connect it with a
bunch of different things. I drive a Tesla. The groc
app just popped up on my screen. The other day,
(24:48):
my kids turned it to the therapist mode and started
asking random questions, and they were asking the really silly questions.
Speaker 2 (24:56):
But what's wrong with daddy?
Speaker 10 (25:01):
You're gonna have to wait a long time to get
that answer.
Speaker 6 (25:05):
Is there is there?
Speaker 4 (25:06):
Is there a big shape shift though in your mind?
Economically in this world, look at it. We know there's
going to be because of blockchain and crypto, But does
AI accelerate that or is it change it or make
a new morph into something we didn't even we're not
even thinking about yet.
Speaker 10 (25:19):
Look, I think it's going to turn into things we
don't think about. But in the short term it's going
to make if we enable it and utilize it, it
can make small businesses and individual people tremendously more efficient.
Speaker 3 (25:34):
Right.
Speaker 10 (25:34):
So, one of our companies this week, and I don't
mean to go from company to company, but one of
our companies this week is at the val Expo in Vegas.
That's the valuation explo It's for appraisers who appraise homes.
The government is actually changing the rules and appraisals. Appraisers,
the guys who come to your house with a clipboard,
(25:56):
take a couple of pictures and then give you a
legally approved appraisal at home. Yeah, they give you the
valuation and when you get that, you can now get
insurance on your home for that amount. You can get
a mortgage for that amount, and that's legally necessary.
Speaker 2 (26:10):
To get those based upon a subjectivity.
Speaker 10 (26:13):
And that person used to take five business days to
get that to you. A really good person would spend
five hours doing that. Our cup well, and on top
of the government is now mandating, starting in the next
couple of months, that they give you more information. So
their job just got harder. So our company IVORY, which
stands for AI Valuation of real Estate, can spit out
(26:35):
those reports in minutes.
Speaker 2 (26:40):
I got a couple of properties to run on a lot.
That's it.
Speaker 10 (26:43):
It's not a blockchain company, but it is digital and
everything's going digital.
Speaker 4 (26:48):
Before Mary gets your question on the blockchain front, in
your mind, does blockchain change how we purchase real estate
in terms of broker and in how we purchase cars
in terms of car salesman, how we purchased stock in
terms of stockbrokers. Is that going to chane things in
the future, you think, because there's no need for that
middleman anymore. If what I'm seeing is accurate.
Speaker 2 (27:05):
Right there.
Speaker 10 (27:07):
There may be need for a middleman, but you and
I can get to have a piece of that middleman
action if we want.
Speaker 4 (27:13):
Okay, now here's what he means by that. So there's
a bit an ask on the trading.
Speaker 2 (27:18):
Box on a stock. So let's say let's say Alan.
Speaker 4 (27:21):
In Selly's tequila company is trading a dollar buy. Uh,
let's say a dollar by dollar fifty. Now that more
actually really a dollar by dollar five.
Speaker 2 (27:28):
Okay.
Speaker 4 (27:30):
The market maker tries to get what's called the spread
in between, and he gets a chunk of that. What
he's talking about is we can get a little bit
of scootsh off of this thing and either save money
from efficiency or bankt for the next transaction.
Speaker 7 (27:42):
Right.
Speaker 10 (27:42):
Yeah, And we used to talk about this defied decentralized
finance being this wild West place because only a small
amount of people have access to it. And my whole
thing was, yes, it would be nice if we could
burn down the legacy financial systems and start fresh and
have everything be awesome them and fair and perfect. But
the truth is that that's not going to happen anytime soon.
(28:05):
JP Morgan is not going to go out of business.
But what will happen is they're going to have to
compete and they make money when they lend us all
all money and we put our money in their accounts
and we get charge fees and sometimes we may earn interest.
That interest is not usually fair compared to how much
they're making off of our money being there. But DeFi
(28:27):
to centralize finance, and these blockchain companies enabling us access
are going to make it easier for the average person
to get a higher interest rate, get a higher yield,
and the banks are going to have to compete with that.
So if you decide I'm not going to get into
this crazy wild West of DeFi and have to learn
to use a tool called meta mask, you won't have to.
You'll probably be able to get that product from your
(28:48):
bank or a product that's similar, And that's the beauty
of how it's going to help the average consumer.
Speaker 5 (28:54):
Hey, Alan, this is actually leading me to my next question,
which I think I ask you about this frequently.
Speaker 2 (29:00):
But what's cryptocurrency?
Speaker 6 (29:02):
Break it down for me the.
Speaker 5 (29:04):
Term regulation and how regulation fits into the blockchain.
Speaker 2 (29:08):
That's a great question.
Speaker 6 (29:08):
How your company is tackling that.
Speaker 10 (29:12):
Yeah, so I used to look at it for the
average American company, as we're going to use technology to
make that regulation burden easier for the average person. Right.
I don't want any of our companies to go full
rogue and do illegal things because that's going to come
back and bite you and that's not going to work.
(29:33):
But we can take something that's complicated and really hard,
Like we always talk about the accredited investor laws and
things like that.
Speaker 2 (29:40):
Real Q's infotainment.
Speaker 4 (29:41):
A credit investor means that there's what's called a big
boy letters what they used to call in the industry,
where you have a certain amount of network, you make
a certain amount of money, or you have a certain
amount of assets uh and.
Speaker 2 (29:50):
That are liquid in terms.
Speaker 4 (29:51):
So you are you are suitable so suitability standard suitable
to make the decision whether you want to invest or not.
Because sometimes you know, you got somebody that's three dollars
in the bank, they're usually sixteen years old.
Speaker 2 (30:02):
They got this great idea'd right, I'm gonna invest in hydroponics.
It's this jeal stuff that you can grow weed in.
Speaker 4 (30:07):
And suddenly you know you're not really you're not really
accredited enough to actually invest in that.
Speaker 2 (30:11):
It's a warning letter. But that accreditation things you bring
up a great point.
Speaker 10 (30:14):
Yeah, yeah, we don't have to go into it, you
know how. We believe about that. But it's a pain
in the butt. It's hard to deal with, and technology
can make it easier. And more and more companies are
allowed to raise money outside of those laws thanks to
regulatory issues, but there's still complications. Technology makes it easier.
So I look at the regulation as something we have
(30:36):
no choice but to comply, So let's use technology to
make it easier. But until recently, there wasn't any regulation
in our space. And even now, you know, Trump may
have signed some declarations and things like that, but it
takes time for the SEC to create the rules make
those things public.
Speaker 1 (30:53):
Along Goren founding partner Draper Goren, blockchain website DGB dot
b Z.
Speaker 2 (31:00):
All right, keep it here.
Speaker 4 (31:05):
LAFT one hundred studios, The Big Biz Show and our
affiliates and our hosts are not registered investment advisors or
broker dealers.
Speaker 8 (31:14):
Our show hosts make no commitment that the purchase of
securities of companies profiled or otherwise mentioned in our.
Speaker 4 (31:19):
Programming are suitable or advisable for any person or than
an investment in such securities will be profitable.
Speaker 2 (31:24):
In general.
Speaker 1 (31:25):
Given the nature of the company's profile and the lack
of an active trading market for the securities, investing is
highly speculative it carries a certain high degree of risk.
We profile selected publicly traded and privately held companies on
our program.
Speaker 10 (31:39):
Most of these companies that we profile have provided compensation
to LAFT one hundred studios and its hosts for the
profile coverage.
Speaker 1 (31:47):
From time to time, we sell shares of the company's
profiled in the open market that we receive as compensation
for coverage of client companies.
Speaker 2 (31:56):
But never sell stocks.
Speaker 1 (31:57):
If we are speaking about interviewing, we're covering up public
company who has paid compensation.
Speaker 8 (32:05):
Specific questions on compensation can be obtained by contacting producer
at Selliandgroup dot com.
Speaker 4 (32:13):
Listeners should verify all claims and do their own due
diligence before investing in any security. As mentioned on this program,
investing in securities as speculatives and carries a high.
Speaker 2 (32:21):
Degree of risk.
Speaker 8 (32:22):
We encourage our investors to invest carefully and read the
investor information available at the websites Onlook.
Speaker 10 (32:27):
Securities and Exchange Commission at sec dot gov and or
the Financial Industry Regulatory Authority FINRA at www dot fr
dot org.
Speaker 3 (32:38):
I like it.
Speaker 2 (32:39):
Hey s a rescue.
Speaker 1 (32:40):
Plan, big big show where the last one hundred studio
in southern California. We know that there's a lot of
you watching worldwide, listening worldwide. I'm American Forces Radio Network.
Speaker 2 (32:54):
We always appreciate you being along for the ride with us.
They are that is the day traded for you, known
of other wise as DTT. Back here at the bars, Tapa,
very godway, there we go.
Speaker 4 (33:05):
Good task Turner, my old friend from Cordova, can he's
the CEO of public traded company. Their socks of well
l v R l F L d r LF, but
in the Canadian Stock Exchange they are c d v
A Cordovacan.
Speaker 2 (33:19):
Of course, as a.
Speaker 4 (33:20):
Retail operator of cannabis products, you haven't heard about that
in a long time. It was interesting because cannabis was
in favor back and I'm going to say and and
uh Taz you can correct me on this, but but
cannabis was in favor in twenty twelve, twenty thirteen, twenty fourteen,
ran out of favor, came back in favor, and now
it's kind of creating its own little lane back again.
(33:42):
It's almost more established and before task. Great to see pal, good, good,
good to talk to you. What give us an overview
of the whole industry because you have gone through the
cyclical sort.
Speaker 2 (33:50):
Of thing in the last decade. Are we now have
a foothold?
Speaker 4 (33:54):
I mean, I know you guys do as retail, but
do you think the cannabis retail space is here to stay?
Speaker 3 (34:00):
Yeah? No, thanks for having me back, Holly. I it's
been a wild ride.
Speaker 11 (34:03):
It's you know, to your point, you know, is in
favor in the twenty twelve through whatever twenty seventeen is timeframe,
went out, went back in, and you know, it's been
out of favor for quite some time. Uh, you know,
we've kept our head down and just growing the business.
But it's it's been a time when a lot of
people have gone out of business. And now obviously there's
a lot of conversation about uh, you know, decriminalizing the
(34:27):
cannabis plant in the US and and so we'll see
if that actually happens here in the coming weeks.
Speaker 3 (34:33):
But there's you know, there's there's certainly a lot of
talk about it in our circle here.
Speaker 11 (34:36):
It's a matter of whether that talk gets a bit
of a broader, a broader reach in the next next
few weeks and months.
Speaker 4 (34:43):
Is it still is the lynch pins still federal banking
regulation because as long as cannabis is federally illegal, not
state's rights, but federal, you can't go to a bank
that is FDIC.
Speaker 2 (34:57):
In short, if you can't do a FIC assured.
Speaker 4 (35:00):
That you guys have you guys are hiding cash in
your walls and which is dangerous.
Speaker 2 (35:04):
Uh is that really what the linchman?
Speaker 3 (35:06):
Is it?
Speaker 4 (35:06):
Once that happens, is this thing is this wild West again?
And then all shows up again in your opinion.
Speaker 3 (35:10):
Yeah, so that's the absolute lynch pin.
Speaker 11 (35:12):
So just this talk of descheduling it, rescheduling it is great,
but that doesn't go far enough to where you know,
we're treated and other cannabis businesses are treated as as
normal businesses operating normal widgets and.
Speaker 3 (35:24):
Things like that.
Speaker 11 (35:25):
So so yeah, that's that's the big that's the big
thing that needs to happen. Obviously, this this descheduling will help,
but it's just the first step.
Speaker 1 (35:34):
Task Turner CEO Cordova can Corporation ticker symbols l v R,
l F Canadian Stock exchange c d v A tas
aside from Canada the United States being on opposite sides
for upcoming.
Speaker 2 (35:48):
World War three?
Speaker 1 (35:49):
How is the Canadian government as far as your business
is concerned, friend or foe.
Speaker 3 (35:56):
It's relatively friendly.
Speaker 11 (35:58):
I'd say that the compliance that they overlay on our
industry in Canada is still, uh, probably a little much
relative to other industries that are that are federally you know,
watched over, so to speak. So uh, they certainly are
are more friendly and and a lot more friendly than
than what we see in the US, but there's a
(36:18):
long way to go.
Speaker 3 (36:18):
We see that there's.
Speaker 7 (36:21):
Still banks and other institutions even in Canada where it's
federally legal, that give the operators of these businesses and
and the people you know like myself a hard time,
uh to be to be to be individuals, you know,
touching the plant, even just in Canada.
Speaker 5 (36:38):
Hey, Taz, I'm Mary. I don't think i've met you before.
Nice to meet you, and I thank you. This is
probably a dumb question, but uh, you.
Speaker 2 (36:45):
Know, I know things, dumb questions, but just dumb people
that ask them.
Speaker 6 (36:48):
That's me anyway.
Speaker 5 (36:52):
True in California, we have dispensaries that are around and
popping up everywhere.
Speaker 2 (36:58):
Which is recreational. Correct.
Speaker 6 (37:00):
That means so is that related to what.
Speaker 5 (37:02):
You guys do, and you guys have anything to do
with these dispensaries and the weed that is sold there.
Speaker 3 (37:08):
Yeah, no, absolutely, So we operate dispensaries in Canada.
Speaker 10 (37:11):
Now.
Speaker 11 (37:12):
We've exited the US for now and obviously have the
ability to get back in when we so choose, but
we've exited the US recently and right now our soul
business is operating retail dispensaries in Canada.
Speaker 4 (37:25):
You know on that question, if you recall and you
and I had this conversation TAZ last year or the
year before whatever, it was probably three years ago when
it went legal here in California. It seemed like we
jumped the shark in terms of getting cannabis legal, not
medicinal cannabinoids, but I'm talking about recreational marijuana use in California,
because there wasn't an infrastructure for safe packaging. There wasn't
(37:46):
a gold standard for if I buy a BAY or
aspirin at CVS, but I buy a CBS aspir at CVS,
I know it's the same thing in.
Speaker 2 (37:52):
Terms of those labels.
Speaker 4 (37:53):
Do you think that's part of it in terms of
going forward to because when the bank stuff drops, is
there enough infrastructure in the US existing now for those
best practices that didn't exist before? Even though we legalize it,
we didn't have the best practice infrastructure in place.
Speaker 3 (38:07):
It's very fragmented. The infrastructure is very fragmented.
Speaker 11 (38:10):
So there's a long way to go in terms of
making the cannabis industry, you know the same as the
bottling industry of.
Speaker 3 (38:17):
Coca Cola or any other.
Speaker 11 (38:18):
CpG you know, consumer packaging, packaged product, you know that's
sold in you know, the walmarts and targets of the world.
Speaker 3 (38:27):
So there's a long way to go.
Speaker 11 (38:28):
I also think though that you know, not only that
it's it's a it's a function of getting the states
uh in the same line, you know, states in line
with way the way the federal government's going to do it,
because right now we have h thirty plus states that
are all operating differently with all different compliance programs, and
so we're going to directify that as there.
Speaker 4 (38:47):
Lies there lies best practice and gold standard correct absolutely right.
Speaker 3 (38:51):
We gotta we got to you know, conform to one
or two one or two or three at most standards.
Here you got to thirty five. It is not good.
Speaker 4 (38:59):
I'm glad that you're on an ongoing basis. Buddy, good
to talk to you, Good.
Speaker 2 (39:03):
To see you again.
Speaker 1 (39:03):
Cast Turner, CEO Cordova can Corporation, ticker symbol Canadian Stock
Exchange c d v A uh here in the States
is l v R l F.
Speaker 2 (39:13):
And that will do it for this version of the
Big Big Show. Thanks to all of you out there
for beat along for the ride. We'll see you again
soon
And over one hundred and seventy five country. Is it
all the ships to see as always? You say, maiki
to the raven and women of our United Armed Forces.
Speaker 2 (00:13):
That is the day traded trio. Are you kind of talented?
What that thing? Sirt?
Speaker 3 (00:17):
Back?
Speaker 2 (00:18):
You're at the bars consta. It's very Godwin and Sully
as the big big show rolls on.
Speaker 4 (00:21):
Hey, nice to see you again with where we will
you tell the audience where you guys were?
Speaker 2 (00:25):
Is that okay? Or is that the personal lily? I
can tell you well because about your kids and stuff.
Speaker 5 (00:28):
I never We were in New York City and the
choreographer create.
Speaker 2 (00:32):
Wait wait, wait, wait do we what in New York?
Speaker 6 (00:35):
We were dancing? I wasn't.
Speaker 2 (00:36):
Your daughter was dancing.
Speaker 5 (00:37):
My two daughters were in a piece that was up
for best choreography.
Speaker 2 (00:42):
And what was this for?
Speaker 5 (00:43):
What was it called the ACE Awards? It started the
dance teachers. It's at in New York every year. Actually
this was the first year back since coach.
Speaker 4 (00:51):
So your kids who are ones went in college, one's
going and finishing high school year. Yeah, and dancings as
long as I've known you, yes, are now making the
big time.
Speaker 5 (00:58):
Well yes, their choreographer. Is that for best choreography? So
their choreographer was the one that received the ward officially.
Speaker 2 (01:04):
Of course he or she is not going to bring
on dancers and aren't.
Speaker 3 (01:07):
Top notes right?
Speaker 5 (01:08):
And all the other dancers there were Broadway dancers or
professional dancing.
Speaker 2 (01:12):
Your keep right up?
Speaker 6 (01:13):
Oh we won? I mean it was.
Speaker 5 (01:15):
And some people don't know who Derek Cuff is, but
you did Derek Cuff.
Speaker 2 (01:20):
From Dancing with You have no idea today, that's crap. Okay,
I have no idea.
Speaker 5 (01:25):
Who was Kenny or Taga or Misty Copelan anyone?
Speaker 7 (01:30):
Well?
Speaker 2 (01:30):
Color she what she said?
Speaker 7 (01:32):
She?
Speaker 6 (01:34):
You tag?
Speaker 5 (01:34):
He choreographedies and my Newsy the movie News, yes, okay.
Speaker 6 (01:42):
And Thanna do which I love.
Speaker 4 (01:43):
But high school musical John Roller Skates.
Speaker 2 (01:48):
We know that one.
Speaker 6 (01:49):
He's a very famous choreographer.
Speaker 2 (01:51):
He want to let him.
Speaker 6 (01:52):
Achieven ore that nice?
Speaker 5 (01:52):
So he was there watching my kids dance. They it
was they were in front of the top dancers of
the whole or was it held in New York City
at the Hilton Midtown's.
Speaker 2 (02:01):
I was just in. How the other celebrities that we
would know?
Speaker 5 (02:04):
Yeah, no, Abby Lead from Dance Moms, any.
Speaker 2 (02:07):
One Oh yeah, I love her rolls, right.
Speaker 6 (02:10):
I don't think it was probably anyone.
Speaker 2 (02:11):
Was Derek Jeter there, former captain of New York game. Yeah, well.
Speaker 4 (02:21):
Some guy that you used to play at the at
the Carlisle. You know that Bobby uh the piano player
of the Carlisle Hotel. No, I don't know what we saw.
Speaker 2 (02:28):
We saw We saw Danny Terrio.
Speaker 4 (02:32):
You know, Danny was one of the most famous dancers
ever in the history of television.
Speaker 2 (02:36):
Is that solid? Yeah?
Speaker 6 (02:38):
Yeah, I do.
Speaker 4 (02:40):
I love how we fought city here. Earlade analyst is
right there, his hood tariffs. How would you ever go
to those dancing sort of sort of.
Speaker 8 (02:51):
Do you ever got every night?
Speaker 2 (02:54):
Did we go to Wicked together? Do you go to
Wicked with me? We go to Wicked together? Were you
at that thing?
Speaker 8 (02:57):
I did?
Speaker 2 (02:58):
I did? Is that we saw New York City. It's fantastic.
Speaker 6 (03:01):
I saw the outsiders?
Speaker 2 (03:02):
Did you do you go to those things? Very often?
How we live in New York? Is that? Do you
spend your time in theater stuff? Very often? Or not
very often?
Speaker 8 (03:09):
You know, they're actually pretty good about giving the local
leader seats away if you if you sign up. So
I have a couple of friends that always so occasionally
I'll get a random Wednesday ticket to a show.
Speaker 5 (03:23):
It's cool you see the outsiders. I admit I just
saw the Outsiders when I was there.
Speaker 2 (03:27):
Written by S. Hinton. That's first book I think I ever read,
or that a Lady of the Tramp can't believe. Hey, how
we uh?
Speaker 4 (03:33):
My question is on this on the trip administration reversing
course allowing limited exports to those chips in exchange for
Nvidia and Amy agreeing to pay some fifteen percent of
their China sales to the government, which is nothing more
than a terror for attacks.
Speaker 2 (03:47):
What do the proponents say of this and what the
what are the opponents say?
Speaker 4 (03:50):
The opponents just think it's a money ground, I'm assuming,
but there's probably a bigger picture going here, don't you think.
Speaker 8 (03:55):
Yeah, the the opponents say it's you know, more than
a tax, because it's kind of like a forced bribe
for letting this happen. Usually what happens is we're more
principled about things with export controls. We say this is
a free market, except we believe this is a national
security threat. We believe that this is you know, a
(04:15):
violation of human rights. So we're not going to allow
this to be exported or this activity to happen. In
this case, we're being transactional about it and saying it's
fifteen percent. I actually am really split in that well,
and I'll tell you why.
Speaker 4 (04:32):
Wait wait wait wait wait, here's my question. Aren't you
happy that China has to have to rely on our chips? Yes,
because we're relying on our vaccines, in our in our antibiotics.
Speaker 2 (04:40):
Right.
Speaker 8 (04:41):
Yeah, No, I mean that's really compelling. I really don't
like the idea of China developing a parallel AI path
where they have the great firewall and censorship ability and
circuit breakers that they're in control of. That that doesn't
appeal to me at all. On the flip side, we've
been doing business.
Speaker 2 (04:59):
You're say that nothing is Yeah, Vidia is not going
to change the.
Speaker 8 (05:03):
World more liberal freedom McDonald's everywhere.
Speaker 4 (05:07):
No, it's true that thirty years of progress as resulted
in zero progress is what you're saying, talk about our
top heavy economy. We have a chart that you've pulled up.
Guys there if you have that back in the in
the controno christy uh viewing our directing as Jared Coleman
once again, no one knows where he is.
Speaker 2 (05:25):
I think I know.
Speaker 4 (05:27):
But talk about what we're looking here. It says net
income growth rebalanced. Actually the top ten top ten.
Speaker 2 (05:32):
What does that?
Speaker 4 (05:32):
What does all that mean to us in terms of
the S and p's biggest companies pulling away from the pack.
Does that mean that we don't need to throw a
dart at the at the Wall Street journaling more to
pick our best docs? We can just we can just
buy buy Spider in exchange traded fund that follows the
S and P.
Speaker 8 (05:46):
Yeah, so this is kind of showing that everything but
the big tech companies are kind of flat. I mean,
this does not account for inflation.
Speaker 1 (05:55):
Uh.
Speaker 8 (05:55):
You see that we have the little dip from Covid
at the beginning on the blue line, and then it
kind of stays flat. It goes up to about one
hundred and twenty percent, but there's been about twenty five
percent cumulative inflation since twenty nineteen. So you know, basically,
if you're not the top ten companies in the S
and P five hundred, you haven't really grown it at all.
(06:16):
So that's what worry.
Speaker 4 (06:18):
But think about this in terms of stock, in terms
of investing and such. If you were to buy the
QQQ that represents a NAZAK one hundred is an exchange
traded fund that is basically that's basically represents the one
hundred Nasdaq socks.
Speaker 2 (06:31):
It's like it's like a mutual fund.
Speaker 4 (06:32):
It's a basket of stocks, but it's traded like a
stock to where it's it's kind of fund manager als.
Speaker 2 (06:36):
So that's QQQ.
Speaker 4 (06:38):
Spy is called the spider. Does the same thing for
the SB five hundred? Are we thinking that S and
P five hundred? And I think it's always you know,
this has always been the benchmark. Is if you dollar
cost average and buy one hundred dollars of sm P
five hundred from the time that you're twenty one years
old till the time that you're fifty five years old,
you're probably gonna be pretty well set in terms of that. Yeah,
this is this change anything. I don't think I don't
(06:58):
think there's any different is it.
Speaker 8 (06:59):
I don't think that that assumption changes. But it does
tell you where the economy is right now. That is, basically,
if you're not one of the top ten big guys,
you're not profitable.
Speaker 2 (07:10):
You're not profitble.
Speaker 8 (07:11):
I mean, yeah, right, And how good can that be?
I could, I could pull this chart for the queues.
There's nothing wrong with the Q index. I so macro
analysis off of the S and P, which is there's.
Speaker 2 (07:24):
Well, what's here's here's what's interesting. Here's what's interesting.
Speaker 4 (07:27):
Profit margins in the seventies or ten twelve percent, that
was a decent pro there's the standard profit margins you'd expect.
Speaker 2 (07:35):
Okay, yep. Profit margins these days are.
Speaker 4 (07:38):
One two percent, mostly across the board, which is not
healthy if you talk about small business, I'm talking about.
Speaker 8 (07:45):
One of the reasons why companies are so popular.
Speaker 2 (07:47):
Yeah, well, because it's a widening gap.
Speaker 4 (07:49):
I mean, is that really what it comes down to
is there's a widening split between what S and P
is doing in the larger companies. Now, is that a
function of more efficiency or is that a function of
just being bigger because you can take it advantage of
a tax code that that we all try to take
advantage of, and and tax avoidance versus tax tax evasion.
Speaker 8 (08:06):
No, I think that's a I think that's a good
call out. The tech companies are first in line and
best able to use the gains from technology, right, so
everyone got more efficient when computers were put in, everyone
got more efficient. When the Internet happened, everyone got more efficient.
When you know Excel became uh used for bookkeeping and
for operations management. I mean, these are all flows that
(08:28):
happened to the tech industry first and then went into
the rest of the economies.
Speaker 2 (08:34):
Part of what we're seeing it it's innovation, is what
you're saying, right.
Speaker 8 (08:37):
Yeah, how companies probably have higher speed of innovation. Yeah.
Speaker 1 (08:41):
How he fund is our market analyst here on the
Big Bis show. Obvious enough looks like Ralf Maccio in
The Outsiders.
Speaker 2 (08:46):
The movie. Howe.
Speaker 1 (08:49):
If we're looking at this chart a year from now,
maybe after terrorists and stuff have taken effect, is the
blue line a little higher up, a little closer to
the purple line?
Speaker 8 (09:00):
Maybe not a year from now. If you take the
bookcase to the tariffs and you say they're going to
bring more manufacturing, more production into the United States for goods,
not necessarily services for goods, then maybe it takes five
years to start seeing an effect. But you're seeing more
produced in the United States now. As far as a growth,
which is what this curve is, you will see that
increase because you will see the production in the US increase,
(09:23):
but you wouldn't necessarily see that in profit margin, like
Selly was saying, because people went offshore because of the
profit margin. The President's just saying, listen, I know you
were making twenty percent by sending it offshore when you
were making ten percent on shore. Well, now you're all
gonna be making nine percent. So pick one. If you're
going to make nine percent, come over to the US.
Speaker 4 (09:41):
Here's my question for you before you get out of here.
Just the biggest surprise. I know the answer to this,
but talk about cumulative inflation since the year right before
COVID started, which the last time I remember was twenty nineteen.
So in the last six years, our cumultive inflation is
what percent?
Speaker 8 (09:55):
Yeah, I mean literally, you're just mathematically. The way to
think about this is you hear the inflation numbers every year,
and what is that number? What goes up? It's become
twenty five nine twenty.
Speaker 4 (10:08):
Five point seven percent inflation in the last six years. Now,
this is why you cannot keep your money. You have
to have your money at risk. You can't keep your
money in a savings account or under the mattress. You've
got to have your money at risk. It's got to
be growing for you with the ups and the downs,
because if you're not, if you don't do that, Howie,
on Monday morning or Friday morning, I want you to
(10:29):
on the air, I want you to explain to everybody
the rule of seventy twos because basically it's going to
tell you how many years, based upon inflation, your money will.
Speaker 2 (10:35):
Be worth half. Right, long story short, there he goes.
HOWI thank you bout appreciate time.
Speaker 1 (10:40):
How we fun market analysts here on the Big Biz Show.
All right, there is much more to come your way.
Please do not go anywhere or back after this big
(11:21):
this show at the beautiful day here in southern California
where are inside the lock one hundred studios. That music
you hear in the background is the world famous, incredibly
talented day Trader Trio. We are lucky enough to be
able to sit and listen to these guys every single
(11:41):
episode of The Big Biz Show. It is Mary burg Goblin.
I am costa little mini edition of None of Business.
Sully will be back in just a second. Gentlemen, thank
you as always, and Mary, we always love talking with
our next guest, John. You is the CEO Cairo's Pharma
and their ticker symbol is KAPA, and doctor U joins
(12:04):
us once again here on the Big Biz Show. Doctor
how are you sir? It is always great to have
you on the program. I hope everything's going well for
you this summer.
Speaker 8 (12:13):
I'm doing good.
Speaker 9 (12:14):
Thank you, Mike, thanks for having me again.
Speaker 2 (12:16):
The last time you were on.
Speaker 4 (12:17):
Since the last time you were on with us, we
have picked up a ton of new platforms where people
can go and view and listen to the Big Biz Show. So,
since we're kind of in that mode right now, can
you just give people quick the nickel version of what
you and Chiro's Pharma are all about and what you do.
Speaker 9 (12:36):
Yeah, sure, we're Chiros Pharma. Our KAPA on the nysc
American is a clinical stage biotech company that's focused on
reversing cancer drug resistance. So one of the biggest problems
in cancer is that the drugs are great, but after
a year or two, patients become resistant to these drugs.
(13:00):
The mechanism by which this happens through a protein called
CD one oh five, And we developed an antibody that
targets this protein and reverse is resistance. So we're in
a phase two trial and prostate cancer and a phase
one trial in lung cancer. We hope to show this
is a central mechanism of cancer drug resistance, not only
(13:21):
these cancers, but head and neck cancer, breast cancer, and
colon cancer. So what our drug does is it allows
drugs that fail to work after some time because of
resistance to start working again. So it works with these
other drugs too, to make patients live longer without the
scorch of cancer. Amazing a chronic disease and not something
(13:43):
that's going to kill patients within a year or two.
Speaker 2 (13:45):
It's amazing to think that.
Speaker 1 (13:46):
You know, if you're a patient, you're like, oh my god,
finally get this wonderful drug, and then after a year
or whatever, you're resistant to it. And even after you
become resistant to it, they can't just bombard you with
higher doses.
Speaker 2 (13:58):
Once you're resistant, that's it. The doors closed. It's not
going to work anymore.
Speaker 9 (14:01):
Yeah, that's what happens. Yeah, it works great until the
day that it doesn't, and then the cancer comes back.
Speaker 8 (14:06):
With a vengeance.
Speaker 9 (14:07):
And so what we want to do is stop that
cancer from coming back, really targeting this central mechanism of resistance.
Speaker 6 (14:15):
So doctor Good to see you again.
Speaker 5 (14:16):
By the way, do you do patients take your treatment
alongside the cancer drug from the beginning or just when
they you know, when you kind of anticipate when they
might start getting well.
Speaker 8 (14:31):
Yeah, that's a good question.
Speaker 9 (14:32):
So it does start after the patient gets resistant to
it or a lot of drugs like to Grisso for
lung cancer. Eighty percent of patients that actually are incompletely
treated with it. So we use our drug on top
of the drug to make them completely treated with with
with the to Grisso as well.
Speaker 1 (14:53):
Doctor John You is the CEO of Cairo's pharma Kai
r Osfarmer dot com. Tick A symbol is Kapa doctor.
If you can boast a little bit.
Speaker 4 (15:04):
I know it happened a while ago, but I think
it's always worth repeating about the grant from the Department
of Defense.
Speaker 8 (15:12):
Yeah.
Speaker 9 (15:12):
Sure, So you know, the Department of Defense gave us
a grant to look at biomarkers for lung cancer study.
What that is is gene tests that'll show which patients
will respond to our drug the best. And that's important
because we've already identified one in prostate cancer. And what
these biomarkers allow us to do is choose those patients
(15:34):
that are going to respond to our drug, and this
makes the likelihood of success of a phase three trial
go from fifty five percent to seventy six percent. So
it really increases the likelihood of success and decreases the
cost of the trial because you can put patients on
that will only the patients that will respond, so that
(15:54):
will make it a much smaller trial, more economic, more effective.
Speaker 6 (16:01):
I have a question.
Speaker 5 (16:02):
You just mentioned the prostate cancer drug, which I think
is the E and V one five.
Speaker 6 (16:08):
Yes, correct, So where you're in the phase two of that?
Is that correct? And tell me a little bit about that.
Speaker 8 (16:14):
Yes.
Speaker 9 (16:14):
So it's a randomized phase two trial where we're adding
our drug to appolludamide, which is the drug that's used
for metastatic castration resistant prostate cancer. So we'll know by
the end of this trial whether our drug really works
in reversing cancer drug resistance. And we're also trying to
show that in lung cancer in a phase one trial.
(16:36):
And so these are first two trials, but it's one
of many that will show which patients can be reversed
from their resistance.
Speaker 1 (16:47):
Doctor as far as prostate cancer is concerned, is it
one of those situations where you really don't know it's
happening until it's too late. Or is it one of
those things where most doctors, if you go in and
get your yearly check up per SE or the blood
tests whatever, can find it and get on top of
(17:08):
it if there is an issue.
Speaker 9 (17:10):
Yeah, so it is important to do examinations and PSA
tests while going on. But you know, by the time
we're eighty years old, about about fifty percent of men
have prostate cancer. Thankfully, generally it's a slow growing cancer.
At some point, you know, it becomes very aggressive and metastatic,
(17:33):
and that's when these drugs and our drugs come in.
Speaker 1 (17:37):
What's coming up as far as Kiro's Farmer is concerned
in the next eighteen months or so.
Speaker 2 (17:42):
Doctor John Hugh is the CEO of Kiro's Farmer, the
Chicker Sibyl Kapa.
Speaker 1 (17:46):
What are you looking at down the road the rest
of the year, maybe going into twenty twenty six.
Speaker 2 (17:51):
Yeah.
Speaker 9 (17:51):
So we reported our safety results last month in July,
and we're planning to release our efficacy results so far
on the prostate cancer trial, and this will be on
September eighteenth. This is the first time we're reporting this actually,
and it's going to be associated with a kol event
or a key opinion leader to talk about our drug
(18:13):
where it would stand in the treatment of a prostate
cancer and the importance of this kind of drug in
this particular disease.
Speaker 6 (18:26):
Hey, doctor, I may have asked you this before, but
I can't remember.
Speaker 5 (18:30):
Is it pretty much that every patient that is treated
for cancer will at some point become resistant to the drugs,
So this would be almost every cancer patient could potentially
use your treatment.
Speaker 9 (18:43):
Yeah, so that's exactly right, and so inevitably people become
resistant to their drugs is just a part of how
cancers work to overcome the therapies that we throw at it.
And that's why it's always a war between you know,
and cancer. And as cancer becomes resistance to our drugs,
(19:04):
then we have to find ways to you know, fight
that resistance, and then of course the cancer will figure
out the means of overcoming you know, the anti resistance
drug too, So we're always, you know, we're always trying
to out battle the cancer.
Speaker 2 (19:19):
Doctor.
Speaker 1 (19:20):
It sounds like it's one of those situations, unfortunately where
you got to hurry up and wait. But you're doing
God's work. I tell you there's so many people out there.
I'm sure everybody in this room knows somebody who's been
stricken or is battling the big fight. As we say,
John U Ceo, Cairo's Farmer, their ticker symbol KAPA website,
Chirosfarmer dot com.
Speaker 2 (19:41):
Doctor. Always great to visit with you.
Speaker 1 (19:43):
Always love hearing about the positive news that Kiro's Farmer
and you are jenerating out there for people who are
stricken with cancer. All right, lots more to come here
on this here Big b Show, Don't go anywhere. Big
(20:05):
Bit Show continues live from the lock Fun Hunter Studios,
Southern California. I'm glad you guys are all along for
this crazy ride that is the DTT day Trader Trio.
Invest in the business, No lessons self taught. Back here
at the bar, it is Costa, it is Mary Burt.
Speaker 2 (20:23):
Godwin, and it is silly. Great to have you a
long today.
Speaker 7 (20:26):
Have you.
Speaker 2 (20:28):
Reconciled the fact that cryptocurrency is here to stay? Absolutely?
Are you ready? Are you ready to trust it?
Speaker 3 (20:34):
No?
Speaker 2 (20:34):
You do already. How much money you have your wallet?
How long has it been there? You have the same pot?
Probably not use your in new York executivity.
Speaker 6 (20:39):
Yes.
Speaker 4 (20:40):
Alon Gorn, of course is the financial technology sector pioneer.
He I met Alon several years ago. I'm gonna say
maybe ten or fifteen years ago. I can't remember how
long it goes. But when he was doing the crowdfunding
came along. And now he is a founding partner of
a company called draper goran blockchain, and they invest in
crypto currency type deals along with early state it's blockchain
(21:01):
and and the digital currency companies.
Speaker 2 (21:03):
And here he is once again. He looks right, he's
right out of Menlo Park, there he is. He looks
just oh, you're cleaning up. I see all right, sand
Hill Road? Is it started to cause people to have
to shave?
Speaker 7 (21:15):
Now?
Speaker 2 (21:15):
I see you up there, buddy. How are you good
to see you?
Speaker 10 (21:19):
You know, actually I shaved just for you guys. The
way the markets are going, we're not going to have
to shave for a while.
Speaker 4 (21:27):
I have a question for you when you're investing in
you guys are a venture firm basically and almost turning
into a private equity firm, and some of your deals
are are maturing. When you're investing in krypto, Now, what
are you invest what? What is it just because the
novelty of crypto and blockchain is gone. Now it's what
are you going to do with it? And how are
we going to maximize it? And I sort of feel
(21:47):
like you remember when the Internet free Thomas Penfield Jackson
laying down the ni trust law or any trust lawsuit
judgment against Microsoft, When we had Netscape and we had
MySpace and Napster, there was a two point on internet,
which which launched Facebook and and and uh and and
the like. I mean, there's definitely a viprecation of dot
(22:08):
com U the dot com bubble as we talk about it,
and IPOs. So we we're still at one point oh
on the crypto and what's one what's two point o
look like? Because you're investing in two point oh already
even though it's not here, correct.
Speaker 10 (22:19):
Yeah, yeah, And and we you know, the way I
look at it is as a firm, we're not really
buying and selling cryptocurrencies, right, Like I've come on here.
We've talked about doge in the past, where the hawktua
coin or things like that. It's not what we do, right.
We invest in technology that we see being enabled and
(22:40):
transferring the industry ten years from now. And so where
we're at as an industry right, are that some of
the companies that we actually helped create in twenty eighteen
that we were coming on the show and talking about
are now finally getting into production with banks like JP
Morgan and stuff like that. So we had a big
exciting announcement on that actually this week with our company
own Era. But what I say when I look at
(23:03):
the industry is I actually have a slide in our deck.
I got to share this with you so you can
bring it on screen one of these times that says
nobody starts an Internet company anymore. And every single letter
in that, or most of the letters in that are
logos from Internet companies. And the reason I say that
is I show that on the screen and then out loud,
I say every company is an.
Speaker 2 (23:24):
Internet company, right exactly.
Speaker 10 (23:25):
So the hot dog stand that we might go to
out lunch is connected to the Internet through seven different
apps and you could order it on your phone if
you want to write there doesn't a company doesn't exist
that isn't an Internet company today. And where we're going
to be in a few years is that every company
will be a blockchain company. But we're not going to
talk about it that way. It's going to be part
of the infrastructure, it's going to be part of the technology,
(23:48):
and we're just going to be.
Speaker 8 (23:49):
Used to it.
Speaker 4 (23:50):
Hey, my question for you is AI, CHATGBT, blockchain and crypto.
You know there's going to be a confluence there that
changes everything, right, Yeah, US a global currency. Everything in
the world is pricing US dollars. I believe it'll stay
the global currency. But let's face it, we are a
fiat currency, mean that we don't have a gold standard,
nor does anybody else. But then here enters AI, and
(24:12):
here enters blockchain and crypto. That's got to change things
in the future. I'm sure we're probably ten years away
from that. But do you have anything on the horizon,
Alon that makes you think that this is going to
be a big change in everyone's life inter nationally?
Speaker 8 (24:25):
Yes?
Speaker 10 (24:26):
Absolutely. I think that user interface in general is totally
changing thanks to AI. We got used to asking Siri
to do things for us, right, like simple things like
making a phone call. But now Siri is directly connected
with chat, GPT, or you can connect it with a
bunch of different things. I drive a Tesla. The groc
app just popped up on my screen. The other day,
(24:48):
my kids turned it to the therapist mode and started
asking random questions, and they were asking the really silly questions.
Speaker 2 (24:56):
But what's wrong with daddy?
Speaker 10 (25:01):
You're gonna have to wait a long time to get
that answer.
Speaker 6 (25:05):
Is there is there?
Speaker 4 (25:06):
Is there a big shape shift though in your mind?
Economically in this world, look at it. We know there's
going to be because of blockchain and crypto, But does
AI accelerate that or is it change it or make
a new morph into something we didn't even we're not
even thinking about yet.
Speaker 10 (25:19):
Look, I think it's going to turn into things we
don't think about. But in the short term it's going
to make if we enable it and utilize it, it
can make small businesses and individual people tremendously more efficient.
Speaker 3 (25:34):
Right.
Speaker 10 (25:34):
So, one of our companies this week, and I don't
mean to go from company to company, but one of
our companies this week is at the val Expo in Vegas.
That's the valuation explo It's for appraisers who appraise homes.
The government is actually changing the rules and appraisals. Appraisers,
the guys who come to your house with a clipboard,
(25:56):
take a couple of pictures and then give you a
legally approved appraisal at home. Yeah, they give you the
valuation and when you get that, you can now get
insurance on your home for that amount. You can get
a mortgage for that amount, and that's legally necessary.
Speaker 2 (26:10):
To get those based upon a subjectivity.
Speaker 10 (26:13):
And that person used to take five business days to
get that to you. A really good person would spend
five hours doing that. Our cup well, and on top
of the government is now mandating, starting in the next
couple of months, that they give you more information. So
their job just got harder. So our company IVORY, which
stands for AI Valuation of real Estate, can spit out
(26:35):
those reports in minutes.
Speaker 2 (26:40):
I got a couple of properties to run on a lot.
That's it.
Speaker 10 (26:43):
It's not a blockchain company, but it is digital and
everything's going digital.
Speaker 4 (26:48):
Before Mary gets your question on the blockchain front, in
your mind, does blockchain change how we purchase real estate
in terms of broker and in how we purchase cars
in terms of car salesman, how we purchased stock in
terms of stockbrokers. Is that going to chane things in
the future, you think, because there's no need for that
middleman anymore. If what I'm seeing is accurate.
Speaker 2 (27:05):
Right there.
Speaker 10 (27:07):
There may be need for a middleman, but you and
I can get to have a piece of that middleman
action if we want.
Speaker 4 (27:13):
Okay, now here's what he means by that. So there's
a bit an ask on the trading.
Speaker 2 (27:18):
Box on a stock. So let's say let's say Alan.
Speaker 4 (27:21):
In Selly's tequila company is trading a dollar buy. Uh,
let's say a dollar by dollar fifty. Now that more
actually really a dollar by dollar five.
Speaker 2 (27:28):
Okay.
Speaker 4 (27:30):
The market maker tries to get what's called the spread
in between, and he gets a chunk of that. What
he's talking about is we can get a little bit
of scootsh off of this thing and either save money
from efficiency or bankt for the next transaction.
Speaker 7 (27:42):
Right.
Speaker 10 (27:42):
Yeah, And we used to talk about this defied decentralized
finance being this wild West place because only a small
amount of people have access to it. And my whole
thing was, yes, it would be nice if we could
burn down the legacy financial systems and start fresh and
have everything be awesome them and fair and perfect. But
the truth is that that's not going to happen anytime soon.
(28:05):
JP Morgan is not going to go out of business.
But what will happen is they're going to have to
compete and they make money when they lend us all
all money and we put our money in their accounts
and we get charge fees and sometimes we may earn interest.
That interest is not usually fair compared to how much
they're making off of our money being there. But DeFi
(28:27):
to centralize finance, and these blockchain companies enabling us access
are going to make it easier for the average person
to get a higher interest rate, get a higher yield,
and the banks are going to have to compete with that.
So if you decide I'm not going to get into
this crazy wild West of DeFi and have to learn
to use a tool called meta mask, you won't have to.
You'll probably be able to get that product from your
(28:48):
bank or a product that's similar, And that's the beauty
of how it's going to help the average consumer.
Speaker 5 (28:54):
Hey, Alan, this is actually leading me to my next question,
which I think I ask you about this frequently.
Speaker 2 (29:00):
But what's cryptocurrency?
Speaker 6 (29:02):
Break it down for me the.
Speaker 5 (29:04):
Term regulation and how regulation fits into the blockchain.
Speaker 2 (29:08):
That's a great question.
Speaker 6 (29:08):
How your company is tackling that.
Speaker 10 (29:12):
Yeah, so I used to look at it for the
average American company, as we're going to use technology to
make that regulation burden easier for the average person. Right.
I don't want any of our companies to go full
rogue and do illegal things because that's going to come
back and bite you and that's not going to work.
(29:33):
But we can take something that's complicated and really hard,
Like we always talk about the accredited investor laws and
things like that.
Speaker 2 (29:40):
Real Q's infotainment.
Speaker 4 (29:41):
A credit investor means that there's what's called a big
boy letters what they used to call in the industry,
where you have a certain amount of network, you make
a certain amount of money, or you have a certain
amount of assets uh and.
Speaker 2 (29:50):
That are liquid in terms.
Speaker 4 (29:51):
So you are you are suitable so suitability standard suitable
to make the decision whether you want to invest or not.
Because sometimes you know, you got somebody that's three dollars
in the bank, they're usually sixteen years old.
Speaker 2 (30:02):
They got this great idea'd right, I'm gonna invest in hydroponics.
It's this jeal stuff that you can grow weed in.
Speaker 4 (30:07):
And suddenly you know you're not really you're not really
accredited enough to actually invest in that.
Speaker 2 (30:11):
It's a warning letter. But that accreditation things you bring
up a great point.
Speaker 10 (30:14):
Yeah, yeah, we don't have to go into it, you
know how. We believe about that. But it's a pain
in the butt. It's hard to deal with, and technology
can make it easier. And more and more companies are
allowed to raise money outside of those laws thanks to
regulatory issues, but there's still complications. Technology makes it easier.
So I look at the regulation as something we have
(30:36):
no choice but to comply, So let's use technology to
make it easier. But until recently, there wasn't any regulation
in our space. And even now, you know, Trump may
have signed some declarations and things like that, but it
takes time for the SEC to create the rules make
those things public.
Speaker 1 (30:53):
Along Goren founding partner Draper Goren, blockchain website DGB dot
b Z.
Speaker 2 (31:00):
All right, keep it here.
Speaker 4 (31:05):
LAFT one hundred studios, The Big Biz Show and our
affiliates and our hosts are not registered investment advisors or
broker dealers.
Speaker 8 (31:14):
Our show hosts make no commitment that the purchase of
securities of companies profiled or otherwise mentioned in our.
Speaker 4 (31:19):
Programming are suitable or advisable for any person or than
an investment in such securities will be profitable.
Speaker 2 (31:24):
In general.
Speaker 1 (31:25):
Given the nature of the company's profile and the lack
of an active trading market for the securities, investing is
highly speculative it carries a certain high degree of risk.
We profile selected publicly traded and privately held companies on
our program.
Speaker 10 (31:39):
Most of these companies that we profile have provided compensation
to LAFT one hundred studios and its hosts for the
profile coverage.
Speaker 1 (31:47):
From time to time, we sell shares of the company's
profiled in the open market that we receive as compensation
for coverage of client companies.
Speaker 2 (31:56):
But never sell stocks.
Speaker 1 (31:57):
If we are speaking about interviewing, we're covering up public
company who has paid compensation.
Speaker 8 (32:05):
Specific questions on compensation can be obtained by contacting producer
at Selliandgroup dot com.
Speaker 4 (32:13):
Listeners should verify all claims and do their own due
diligence before investing in any security. As mentioned on this program,
investing in securities as speculatives and carries a high.
Speaker 2 (32:21):
Degree of risk.
Speaker 8 (32:22):
We encourage our investors to invest carefully and read the
investor information available at the websites Onlook.
Speaker 10 (32:27):
Securities and Exchange Commission at sec dot gov and or
the Financial Industry Regulatory Authority FINRA at www dot fr
dot org.
Speaker 3 (32:38):
I like it.
Speaker 2 (32:39):
Hey s a rescue.
Speaker 1 (32:40):
Plan, big big show where the last one hundred studio
in southern California. We know that there's a lot of
you watching worldwide, listening worldwide. I'm American Forces Radio Network.
Speaker 2 (32:54):
We always appreciate you being along for the ride with us.
They are that is the day traded for you, known
of other wise as DTT. Back here at the bars, Tapa,
very godway, there we go.
Speaker 4 (33:05):
Good task Turner, my old friend from Cordova, can he's
the CEO of public traded company. Their socks of well
l v R l F L d r LF, but
in the Canadian Stock Exchange they are c d v
A Cordovacan.
Speaker 2 (33:19):
Of course, as a.
Speaker 4 (33:20):
Retail operator of cannabis products, you haven't heard about that
in a long time. It was interesting because cannabis was
in favor back and I'm going to say and and
uh Taz you can correct me on this, but but
cannabis was in favor in twenty twelve, twenty thirteen, twenty fourteen,
ran out of favor, came back in favor, and now
it's kind of creating its own little lane back again.
(33:42):
It's almost more established and before task. Great to see pal, good, good,
good to talk to you. What give us an overview
of the whole industry because you have gone through the
cyclical sort.
Speaker 2 (33:50):
Of thing in the last decade. Are we now have
a foothold?
Speaker 4 (33:54):
I mean, I know you guys do as retail, but
do you think the cannabis retail space is here to stay?
Speaker 3 (34:00):
Yeah? No, thanks for having me back, Holly. I it's
been a wild ride.
Speaker 11 (34:03):
It's you know, to your point, you know, is in
favor in the twenty twelve through whatever twenty seventeen is timeframe,
went out, went back in, and you know, it's been
out of favor for quite some time. Uh, you know,
we've kept our head down and just growing the business.
But it's it's been a time when a lot of
people have gone out of business. And now obviously there's
a lot of conversation about uh, you know, decriminalizing the
(34:27):
cannabis plant in the US and and so we'll see
if that actually happens here in the coming weeks.
Speaker 3 (34:33):
But there's you know, there's there's certainly a lot of
talk about it in our circle here.
Speaker 11 (34:36):
It's a matter of whether that talk gets a bit
of a broader, a broader reach in the next next
few weeks and months.
Speaker 4 (34:43):
Is it still is the lynch pins still federal banking
regulation because as long as cannabis is federally illegal, not
state's rights, but federal, you can't go to a bank
that is FDIC.
Speaker 2 (34:57):
In short, if you can't do a FIC assured.
Speaker 4 (35:00):
That you guys have you guys are hiding cash in
your walls and which is dangerous.
Speaker 2 (35:04):
Uh is that really what the linchman?
Speaker 3 (35:06):
Is it?
Speaker 4 (35:06):
Once that happens, is this thing is this wild West again?
And then all shows up again in your opinion.
Speaker 3 (35:10):
Yeah, so that's the absolute lynch pin.
Speaker 11 (35:12):
So just this talk of descheduling it, rescheduling it is great,
but that doesn't go far enough to where you know,
we're treated and other cannabis businesses are treated as as
normal businesses operating normal widgets and.
Speaker 3 (35:24):
Things like that.
Speaker 11 (35:25):
So so yeah, that's that's the big that's the big
thing that needs to happen. Obviously, this this descheduling will help,
but it's just the first step.
Speaker 1 (35:34):
Task Turner CEO Cordova can Corporation ticker symbols l v R,
l F Canadian Stock exchange c d v A tas
aside from Canada the United States being on opposite sides
for upcoming.
Speaker 2 (35:48):
World War three?
Speaker 1 (35:49):
How is the Canadian government as far as your business
is concerned, friend or foe.
Speaker 3 (35:56):
It's relatively friendly.
Speaker 11 (35:58):
I'd say that the compliance that they overlay on our
industry in Canada is still, uh, probably a little much
relative to other industries that are that are federally you know,
watched over, so to speak. So uh, they certainly are
are more friendly and and a lot more friendly than
than what we see in the US, but there's a
(36:18):
long way to go.
Speaker 3 (36:18):
We see that there's.
Speaker 7 (36:21):
Still banks and other institutions even in Canada where it's
federally legal, that give the operators of these businesses and
and the people you know like myself a hard time,
uh to be to be to be individuals, you know,
touching the plant, even just in Canada.
Speaker 5 (36:38):
Hey, Taz, I'm Mary. I don't think i've met you before.
Nice to meet you, and I thank you. This is
probably a dumb question, but uh, you.
Speaker 2 (36:45):
Know, I know things, dumb questions, but just dumb people
that ask them.
Speaker 6 (36:48):
That's me anyway.
Speaker 5 (36:52):
True in California, we have dispensaries that are around and
popping up everywhere.
Speaker 2 (36:58):
Which is recreational. Correct.
Speaker 6 (37:00):
That means so is that related to what.
Speaker 5 (37:02):
You guys do, and you guys have anything to do
with these dispensaries and the weed that is sold there.
Speaker 3 (37:08):
Yeah, no, absolutely, So we operate dispensaries in Canada.
Speaker 10 (37:11):
Now.
Speaker 11 (37:12):
We've exited the US for now and obviously have the
ability to get back in when we so choose, but
we've exited the US recently and right now our soul
business is operating retail dispensaries in Canada.
Speaker 4 (37:25):
You know on that question, if you recall and you
and I had this conversation TAZ last year or the
year before whatever, it was probably three years ago when
it went legal here in California. It seemed like we
jumped the shark in terms of getting cannabis legal, not
medicinal cannabinoids, but I'm talking about recreational marijuana use in California,
because there wasn't an infrastructure for safe packaging. There wasn't
(37:46):
a gold standard for if I buy a BAY or
aspirin at CVS, but I buy a CBS aspir at CVS,
I know it's the same thing in.
Speaker 2 (37:52):
Terms of those labels.
Speaker 4 (37:53):
Do you think that's part of it in terms of
going forward to because when the bank stuff drops, is
there enough infrastructure in the US existing now for those
best practices that didn't exist before? Even though we legalize it,
we didn't have the best practice infrastructure in place.
Speaker 3 (38:07):
It's very fragmented. The infrastructure is very fragmented.
Speaker 11 (38:10):
So there's a long way to go in terms of
making the cannabis industry, you know the same as the
bottling industry of.
Speaker 3 (38:17):
Coca Cola or any other.
Speaker 11 (38:18):
CpG you know, consumer packaging, packaged product, you know that's
sold in you know, the walmarts and targets of the world.
Speaker 3 (38:27):
So there's a long way to go.
Speaker 11 (38:28):
I also think though that you know, not only that
it's it's a it's a function of getting the states
uh in the same line, you know, states in line
with way the way the federal government's going to do it,
because right now we have h thirty plus states that
are all operating differently with all different compliance programs, and
so we're going to directify that as there.
Speaker 4 (38:47):
Lies there lies best practice and gold standard correct absolutely right.
Speaker 3 (38:51):
We gotta we got to you know, conform to one
or two one or two or three at most standards.
Here you got to thirty five. It is not good.
Speaker 4 (38:59):
I'm glad that you're on an ongoing basis. Buddy, good
to talk to you, Good.
Speaker 2 (39:03):
To see you again.
Speaker 1 (39:03):
Cast Turner, CEO Cordova can Corporation, ticker symbol Canadian Stock
Exchange c d v A uh here in the States
is l v R l F.
Speaker 2 (39:13):
And that will do it for this version of the
Big Big Show. Thanks to all of you out there
for beat along for the ride. We'll see you again
soon
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
New Heights with Jason & Travis Kelce
Football’s funniest family duo — Jason Kelce of the Philadelphia Eagles and Travis Kelce of the Kansas City Chiefs — team up to provide next-level access to life in the league as it unfolds. The two brothers and Super Bowl champions drop weekly insights about the weekly slate of games and share their INSIDE perspectives on trending NFL news and sports headlines. They also endlessly rag on each other as brothers do, chat the latest in pop culture and welcome some very popular and well-known friends to chat with them. Check out new episodes every Wednesday. Follow New Heights on the Wondery App, YouTube or wherever you get your podcasts. You can listen to new episodes early and ad-free, and get exclusive content on Wondery+. Join Wondery+ in the Wondery App, Apple Podcasts or Spotify. And join our new membership for a unique fan experience by going to the New Heights YouTube channel now!